Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

1997 Annals of Internal Medicine 282 citations

Abstract

For an individual patient, a change in plasma HIV-1 RNA level of 2.5-fold or more probably indicates a true biological change. Monitoring HIV-1 RNA levels and CD4+ lymphocytes before a change in antiretroviral treatment and monitoring HIV-1 RNA levels shortly thereafter improves prediction of disease progression and decline in CD4+ counts for 1 year compared with monitoring CD4+ counts of HIV-1 RNA levels alone. Additional monitoring of infectious HIV-1 titers in mononuclear cells of peripheral blood is not useful.

Keywords

MedicineZidovudineImmunologyDidanosineInternal medicineViral loadLamivudineLymphocyteLentivirusNevirapineImmunopathologyClinical trialViral diseaseVirusAntiretroviral therapy

Affiliated Institutions

Related Publications

Publication Info

Year
1997
Type
article
Volume
126
Issue
12
Pages
929-938
Citations
282
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

282
OpenAlex

Cite This

Michael D. Hughes (1997). Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response. Annals of Internal Medicine , 126 (12) , 929-938. https://doi.org/10.7326/0003-4819-126-12-199706150-00001

Identifiers

DOI
10.7326/0003-4819-126-12-199706150-00001